Showing results (331-340 of 449) with videos related to
Sort By:
Pageof 45
Gynecologic Oncology|July 10, 2020
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survivalKatharine K Brieger, Siri Peterson, Alice W Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2017
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association ConsortiumAlbina N Minlikeeva, Jo L Freudenheim, Kevin H Eng, et al.Cancer Research|March 12, 2009
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancerJoellen M Schildkraut, Ellen L Goode, Merlise A Clyde, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium studyJennifer A Doherty, Mary Anne Rossing, Kara L Cushing-Haugen, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2008
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white womenRachel T Palmieri, Melanie A Wilson, Edwin S Iversen, et al.Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.HGG Advances|July 28, 2021
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancerSiddhartha P Kar, Daniel P C Considine, Jonathan P Tyrer, et al.Plos Genetics|July 15, 2010
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"Sharon E Johnatty, Jonathan Beesley, Xiaoqing Chen, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 7, 2013
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancerCeleste Leigh Pearce, Mary Anne Rossing, Alice W Lee, et al.Pageof 45